Literature DB >> 19847462

Inter- and intrapatients comparison of WHO grade II glioma kinetics before and after surgical resection.

Emmanuel Mandonnet1, Johan Pallud, Denys Fontaine, Luc Taillandier, Luc Bauchet, Philippe Peruzzi, Jacques Guyotat, Valérie Bernier, Marie-Hélène Baron, Hugues Duffau, Laurent Capelle.   

Abstract

Grade II gliomas grow slowly and linearly (at rates about 4 mm/year) before undergoing anaplastic transformation. In order to analyze how surgery may affect radiological grade II glioma kinetics, we restrospectively reviewed our national database searching for patients operated on for a supratentorial grade II glioma between 1997 and 2007. We selected patients with at least two postoperative MRI with a minimal delay of 6 months. For each patient, postoperative residues were segmented on successive MRIs. Velocities of diameter expansion were estimated by linear regression of mean diameter evolution for each patient. Fifty-four patients fulfilled inclusion criteria. Median postoperative follow-up was 1.6 years with, on average, 3.4 MRI examinations per patient. Postoperative growth rates of mean diameter were normally distributed, around a mean value of 4.3 mm/year (SD = 3.2 mm/year). Statistical analysis showed no difference between this distribution and the distribution of preoperative growth rates in a previous series of 143 grade II gliomas. For a subset of 23 patients, delay between first MRI and surgery made it possible to estimate also preoperative growth rates. Intrapatient comparison revealed that growth rates were grossly unchanged for 80% of cases. In summary, inter- and intrapatient comparison of pre- and postoperative growth rates proves that surgery does not change grade II glioma dynamics, thus, acting as a cytoreduction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19847462     DOI: 10.1007/s10143-009-0229-x

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  16 in total

1.  O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas.

Authors:  Dirk Pauleit; Frank Floeth; Kurt Hamacher; Markus J Riemenschneider; Guido Reifenberger; Hans-Wilhelm Müller; Karl Zilles; Heinz H Coenen; Karl-Josef Langen
Journal:  Brain       Date:  2005-02-02       Impact factor: 13.501

Review 2.  Computational modeling of the WHO grade II glioma dynamics: principles and applications to management paradigm.

Authors:  Emmanuel Mandonnet; Johan Pallud; Olivier Clatz; Luc Taillandier; Ender Konukoglu; Hugues Duffau; Laurent Capelle
Journal:  Neurosurg Rev       Date:  2008-02-26       Impact factor: 3.042

3.  Integrated positron emission tomography and magnetic resonance imaging-guided resection of brain tumors: a report of 103 consecutive procedures.

Authors:  Benoît Pirotte; Serge Goldman; Olivier Dewitte; Nicolas Massager; David Wikler; Florence Lefranc; Nordeyn Oulad Ben Taib; Sandrine Rorive; Philippe David; Jacques Brotchi; Marc Levivier
Journal:  J Neurosurg       Date:  2006-02       Impact factor: 5.115

4.  Serial diffusion-weighted magnetic resonance imaging in cases of glioma: distinguishing tumor recurrence from postresection injury.

Authors:  Justin S Smith; Soonmee Cha; Mary Catherine Mayo; Michael W McDermott; Andrew T Parsa; Susan M Chang; William P Dillon; Mitchel S Berger
Journal:  J Neurosurg       Date:  2005-09       Impact factor: 5.115

5.  Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas.

Authors:  Matthew J McGirt; Kaisorn L Chaichana; Frank J Attenello; Jon D Weingart; Khoi Than; Peter C Burger; Alessandro Olivi; Henry Brem; Alfredo Quinoñes-Hinojosa
Journal:  Neurosurgery       Date:  2008-10       Impact factor: 4.654

6.  Prognostic significance of imaging contrast enhancement for WHO grade II gliomas.

Authors:  Johan Pallud; Laurent Capelle; Luc Taillandier; Denys Fontaine; Emmanuel Mandonnet; Rémy Guillevin; Luc Bauchet; Philippe Peruzzi; Florence Laigle-Donadey; Michèle Kujas; Jacques Guyotat; Marie-Hélène Baron; Karima Mokhtari; Hugues Duffau
Journal:  Neuro Oncol       Date:  2008-08-12       Impact factor: 12.300

7.  Dynamic history of low-grade gliomas before and after temozolomide treatment.

Authors:  Damien Ricard; Gentian Kaloshi; Alexandra Amiel-Benouaich; Julie Lejeune; Yannick Marie; Emmanuel Mandonnet; Michèle Kujas; Karima Mokhtari; Sophie Taillibert; Florence Laigle-Donadey; Antoine F Carpentier; Antonio Omuro; Laurent Capelle; Hugues Duffau; Philippe Cornu; Rémy Guillevin; Marc Sanson; Khê Hoang-Xuan; Jean-Yves Delattre
Journal:  Ann Neurol       Date:  2007-05       Impact factor: 10.422

8.  Volumes and growth rates of untreated adult low-grade gliomas indicate risk of early malignant transformation.

Authors:  Jeremy Rees; Hilary Watt; H Rolf Jäger; Chris Benton; Daniel Tozer; Paul Tofts; Adam Waldman
Journal:  Eur J Radiol       Date:  2008-07-15       Impact factor: 3.528

9.  Inflammation is responsible for the development of wound-induced tumors in chickens infected with Rous sarcoma virus.

Authors:  M Martins-Green; N Boudreau; M J Bissell
Journal:  Cancer Res       Date:  1994-08-15       Impact factor: 12.701

10.  Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas.

Authors:  Justin S Smith; Edward F Chang; Kathleen R Lamborn; Susan M Chang; Michael D Prados; Soonmee Cha; Tarik Tihan; Scott Vandenberg; Michael W McDermott; Mitchel S Berger
Journal:  J Clin Oncol       Date:  2008-03-10       Impact factor: 44.544

View more
  18 in total

1.  Improving the time-machine: estimating date of birth of grade II gliomas.

Authors:  C Gerin; J Pallud; B Grammaticos; E Mandonnet; C Deroulers; P Varlet; L Capelle; L Taillandier; L Bauchet; H Duffau; M Badoual
Journal:  Cell Prolif       Date:  2011-12-14       Impact factor: 6.831

2.  Dynamic imaging response following radiation therapy predicts long-term outcomes for diffuse low-grade gliomas.

Authors:  Johan Pallud; Jean-François Llitjos; Frédéric Dhermain; Pascale Varlet; Edouard Dezamis; Bertrand Devaux; Raphaëlle Souillard-Scémama; Nader Sanai; Maria Koziak; Philippe Page; Michel Schlienger; Catherine Daumas-Duport; Jean-François Meder; Catherine Oppenheim; François-Xavier Roux
Journal:  Neuro Oncol       Date:  2012-03-13       Impact factor: 12.300

3.  Prolonged response without prolonged chemotherapy: a lesson from PCV chemotherapy in low-grade gliomas.

Authors:  Matthieu Peyre; Stéphanie Cartalat-Carel; David Meyronet; Damien Ricard; Anne Jouvet; Johan Pallud; Karima Mokhtari; Jacques Guyotat; Emmanuel Jouanneau; Marie-Pierre Sunyach; Didier Frappaz; Jérôme Honnorat; François Ducray
Journal:  Neuro Oncol       Date:  2010-05-20       Impact factor: 12.300

4.  A new tool for grade II glioma studies: plotting cumulative time with quality of life versus time to malignant transformation.

Authors:  Emmanuel Mandonnet; Hugues Duffau; Luc Bauchet
Journal:  J Neurooncol       Date:  2011-07-09       Impact factor: 4.130

5.  Velocity of tumor spontaneous expansion predicts long-term outcomes for diffuse low-grade gliomas.

Authors:  Johan Pallud; Marie Blonski; Emmanuel Mandonnet; Etienne Audureau; Denys Fontaine; Nader Sanai; Luc Bauchet; Philippe Peruzzi; Marc Frénay; Philippe Colin; Rémy Guillevin; Valérie Bernier; Marie-Hélène Baron; Jacques Guyotat; Hugues Duffau; Luc Taillandier; Laurent Capelle
Journal:  Neuro Oncol       Date:  2013-02-07       Impact factor: 12.300

6.  Is a prospective trial necessary to suggest a clinical relevance?

Authors:  Johan Pallud; Hugues Duffau
Journal:  Neuro Oncol       Date:  2014-08-05       Impact factor: 12.300

7.  Long-term impact of temozolomide on 1p/19q-codeleted low-grade glioma growth kinetics.

Authors:  C Izquierdo; A Alentorn; A Idbaih; M Simó; G Kaloshi; D Ricard; M Barritault; D Meyronet; J Bruna; J Honnorat; J Y Delattre; F Ducray
Journal:  J Neurooncol       Date:  2017-11-15       Impact factor: 4.130

8.  Imaging growth as a predictor of grade of malignancy and aggressiveness of IDH-mutant and 1p/19q-codeleted oligodendrogliomas in adults.

Authors:  Alexandre Roux; Arnault Tauziede-Espariat; Marc Zanello; Sophie Peeters; Gilles Zah-Bi; Eduardo Parraga; Myriam Edjlali; Emmanuèle Lechapt; Natalia Shor; Luisa Bellu; Giulia Berzero; Didier Dormont; Edouard Dezamis; Fabrice Chretien; Catherine Oppenheim; Marc Sanson; Pascale Varlet; Laurent Capelle; Frédéric Dhermain; Johan Pallud
Journal:  Neuro Oncol       Date:  2020-07-07       Impact factor: 12.300

9.  1P19Q loss but not IDH1 mutations influences WHO grade II gliomas spontaneous growth.

Authors:  Catherine Gozé; Charlotte Bezzina; Eric Gozé; Valérie Rigau; Thierry Maudelonde; Luc Bauchet; Hugues Duffau
Journal:  J Neurooncol       Date:  2012-03-06       Impact factor: 4.130

Review 10.  Awake surgery for hemispheric low-grade gliomas: oncological, functional and methodological differences between pediatric and adult populations.

Authors:  Gianluca Trevisi; Thomas Roujeau; Hugues Duffau
Journal:  Childs Nerv Syst       Date:  2016-09-20       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.